EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Structure‐Based Drug Discovery with Deep Learning**

R Özçelik iD, D van Tilborg iD, J Jiménez-Luna iD, F Grisoni iD

ChemBioChem · 03.07.2023 · 24 (13)

DOI: 10.1002/cbic.202200776 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 13.06.2023. Verfasst von R Özçelik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Complex Molecular Systems and Dept. Biomedical Engineering, Eindhoven University of Technology, 5612 AZ, Eindhoven, The Netherlands. Hauptthemen laut MEDLINE: Artificial Intelligence, Deep Learning. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) in the form of deep learning has promise for drug discovery and chemical biology, for example, to predict protein structure and molecular bioactivity, plan organic synthesis, and design molecules de novo . While most of the deep learning efforts in drug discovery have focused on ligand‐based approaches, structure‐based drug discovery has the potential to tackle unsolved challenges, such as affinity prediction for unexplored protein targets, binding‐mechanism elucidation, and the rationalization of related chemical kinetic properties. Advances in deep‐learning methodologies and the availability of accurate predictions for protein tertiary structure advocate for a renaissance in structure‐based approaches for drug discovery guided by AI. This review summarizes the most prominent algorithmic concepts in structure‐based deep learning for drug discovery, and forecasts opportunities, applications, and challenges ahead.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDeep LearningDrug DiscoveryKineticsDrug Design

Stichwörter der Autor:innen

artificial intelligencede novo designmachine learningmedicinal chemistrystructural biology

Autor:innen und Institutionen

  • Institute for Complex Molecular Systems and Dept. Biomedical Engineering, Eindhoven University of Technology, 5612 AZ, Eindhoven, The Netherlands.
  • Alliance TU/e, WUR, UU, UMC, Centre for Living Technologies, 3584 CB, Utrecht, The Netherlands.
  • AI4Science, Microsoft Research, Cambridge, CB1 2FB, UK.

ORCID-Profile: R Özçelik, D van Tilborg, J Jiménez-Luna, F Grisoni

Zitieren

APA

Özçelik, R., van Tilborg, D., Jiménez-Luna, J., & Grisoni, F. (2023). Structure‐Based Drug Discovery with Deep Learning**. ChemBioChem, 24(13). https://doi.org/10.1002/cbic.202200776

Vancouver

Özçelik R, van Tilborg D, Jiménez-Luna J, Grisoni F. Structure‐Based Drug Discovery with Deep Learning**. ChemBioChem. 2023;24(13). doi:10.1002/cbic.202200776

BibTeX
@article{zelik2023,
  author = {Özçelik, R and van Tilborg, D and Jiménez-Luna, J and Grisoni, F},
  title = {Structure‐Based Drug Discovery with Deep Learning**},
  journal = {ChemBioChem},
  year = {2023},
  volume = {24},
  number = {13},
  doi = {10.1002/cbic.202200776}
}
Kostenlos starten →